Example: Heart Attack

Search clinical trials for: Mace

Total 85 results

NCT01728129

Completed

DANA Compared to MACE in Evaluation of Suspected Acute Concussion

Conditions: Brain Concussion; Traumatic Brain Injury
NCT03185598

Completed

MACE and First Operating Room Systolic Blood Pressure in Patients Undergoing Non-cardiac Surgery Implications for the Hypertension Threshold

Conditions: Major Adverse Cardiac-cerebral-kidney Event
NCT02184884

Completed

Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrome Undergoing Off-pump Coronary Artery Bypass Surgery

Conditions: Acute Coronary Syndrome (ACS)
NCT03300908

Completed

Contextualizing & Responding to HIV Risk Behaviors

Conditions: Human Immunodeficiency Virus
NCT00927160

Completed

Evaluation of the Mobile Acute Care of the Elderly (MACE) Unit

Conditions: Model of Care for Hospitalized Older Adults
NCT02690376

Completed

An Observer Blinded Comparison of MACE and Conventional Upper Gastrointestinal Endoscopy in Upper GI Bleeding

Conditions: Gastrointestinal Diseases
NCT03627039

Active, not recruiting

Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)

Conditions: Diabetes Mellitus, Type 2
NCT04270344

Recruiting

The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

Conditions: Hypercholesterolemia
NCT01930214

Completed

Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)

Conditions: Coronary Artery Disease
NCT01173939

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments

Conditions: Hypercholesterolemia; Type 2 Diabetes; Hypertension
NCT02069717

Withdrawn

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

Conditions: Metabolic Syndrome
NCT02852161

Unknown status

The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study

Conditions: Barrett's Oesophagus; Oesophageal Varices
NCT00426049

Unknown status

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Conditions: Coronary Artery Disease; Coronary Restenosis
NCT03947853

Withdrawn

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Conditions: Heart Failure; Heart Failure NYHA Class III; Heart Failure NYHA Class II; Heart Failure NYHA Class IV
NCT00116012

Completed

Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32

Conditions: Coronary Disease
NCT03583047

Unknown status

Intracoronary Features in the Prognosis of Endothelial Dysfunction and MACES in Population With Acute Coronary Syndrome

Conditions: Endothelial Dysfunction; Cardiovascular Risk Factor; Coronary Syndrome, Acute
NCT04349982

Recruiting

ICU Trial in Critical Ill COVID-19 Patients

Conditions: Risk Factor, Cardiovascular; Covid19; Critical Illness; Course Illness
NCT03968809

Recruiting

Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes

Conditions: Coronary Artery Disease
NCT03518034

Recruiting

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Conditions: Hypogonadism; Cardiovascular Diseases
NCT00868855

Terminated

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Conditions: Coronary Artery Disease
NCT01000727

Completed

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Conditions: Acute Coronary Syndrome
NCT00799903

Completed

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Conditions: Atherosclerosis
NCT01601704

Terminated

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Conditions: Obesity; Overweight
NCT02663908

Active, not recruiting

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Conditions: Prostate Cancer
NCT02586155

Active, not recruiting

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease; Cardiovascular Diseases